newsfilter
← Latest News
GlobeNewswire·

Monopar to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

WILMETTE, Ill., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (NASDAQ:MNPR), a clinical-stage biopharmaceutical company focused on developing innovative treatments for cancer patients, today announced